Aker BioMarine ASA · OSL:AKBM

Aker BioMarine ASA — Q1 2010 Earnings Presentation

17 slides from Aker BioMarine ASA's earnings presentation, 2010

  1. Slide 1: Continued improvement Q1 2010

    Aker BioMarine Continued improvement Q1 2010 Hallvard Muri, CEO Fredrik Dokk Nygaard, CFO Matts Johansen, EVP Sales & Marketing Th preferred The f d partner t part of Aker

  2. Slide 2: Highlights Q1 2010

    Aker BioMarine Highlights Q1 2010 ƒ Good fisheries and QrillTM production 146% higher than Q1 2009 ƒ Increased production capacity with new facility ƒ Continued revenue growth for both SuperbaTM Krill and QrillTM ƒ Break through in Europe with new contract of minimum 30 MT through 2011 ƒ 8,500 MT Qr

  3. Slide 3: Key performance indicators

    Aker BioMarine Key performance indicators Last five quarters (Q1/09 – Q1/10) Operating revenues EBITDA Cash flow from operations NOK million NOK million NOK million - - 60 50 52 -20 -7 -10 -15 50 41 -11 -40 -20 -40 40 34 -22 -60 -52 30 -30 20 -80 20 -40 -36 -100 -41 10 -50 -120 -48 -118 - -60 -140 Q

  4. Slide 4: Income statement

    Q1 2010 Income statement Income statement Actual Actual Actual Actual Actual Actual Actual YTD YTD Year Amounts in NOK million Q1 2009 Q2 2009 Q3 2009 Q4 2009 Q1 2010 2009 2010 2009 Operating revenues 20 34 41 50 52 20 52 145 Cost of goods purchased (11) (13) (14) (10) (20) (11) (20) (48) Inventory

  5. Slide 5: Balance sheet and cash flow

    Q1 2010 Balance sheet and cash flow Balance sheet Q4/09 Q1/10 Q1/09 YE 2009 Total assets 1 621 1 648 1 738 1 621 Total equity 196 166 418 196 Net interest bearing b d debt b 836 890 674 836 Equity % (including convertible debt) 38% 36% 46% 38% Cash flow Q4/09 Q / Q1/10 Q / Q1/09 Q / YTD Cash flow fr

  6. Slide 6: Refinancing: Status – progressing according to plan

    Refinancing Status – progressing according to plan ƒ February 8 • Outline refinancing plan communicated ƒ March 10 • Solution with bondholders communicated • Planned share issue announced ƒ March 15 • Announced A d proposed d terms t off the th share h issue i ƒ April 8 • Annual shareholders meeting

  7. Slide 7: Positioning and sales strategy for Qrill successfully implemented

    The positioning‐ and sales‐strategy for Qrill has successfully f ll been b implemented l d Sales success Marketingg success ƒ New sales strategy for QrillTM ƒ Differentiated positioning successfully implemented ƒ QrillTM value started to be ƒ Majority of 2010 supply already recognized committed ƒ Pr

  8. Slide 8: Superba Krill's markets are expanding

    Superba™ Krill’s markets are expanding Regional distribution ƒ Currently 54 customers in Europe ƒ Followingg Novel Food Approval pp the majority j y Europe 15% 27% are preparing or have recently launched Europe their Superba™ products ƒ Superba™ Krill to be included in an existing product with stron

  9. Slide 9: Following Novel Food Approval several brands have reached European consumers

    Following Novel Food Approval several brands have found their way to European consumers… consumers Claims: ƒ Krill Oil ‐ your new high strength source of Omega‐3 ƒ May help support a healthy heart Distribution in the UK: ƒ Holland & Barrett, Pharmacy2U ƒ All major wholesalers distributing to p in th

  10. Slide 10: Supported by well executed marketing campaigns

    …supported by well executed marketing campaigns Example from Swedish underground advertising Th preferred The f d partner t 10 part of Aker © Aker |

  11. Slide 11: Aker BioMarine signed an important agreement for the European market

    Aker BioMarine signed an important agreement for the European market k About the agreement Importance for Aker BioMarine ƒ Good volumes from day one ƒ 5 year exclusive supply agreement ƒ Superba ™ Krill linked to a well established brand ƒ Options for additional 6 years ƒ Significant marketing spend

  12. Slide 12: Superba Krill's markets are expanding

    Superba™ Krill’s markets are expanding Regional distribution ƒ Currently 54 customers in Europe ƒ Followingg Novel Food Approval pp the majority j y Europe 15% 27% are preparing or have recently launched Europe their Superba™ products ƒ Superba™ Krill to be included in an existing product with stron

  13. Slide 13: Consumer awareness is growing, fuelled by media and satisfied users

    Consumer awareness is growing, fuelled by media and rapidly growing number of satisfied users Dr. Mehmet Oz ƒ Cardiothoracic surgeon and teaching Example: Krill feature in the Dr. Oz show professor at Columbia University ƒ The Dr. Oz Show ‐ watched by 4 million Americans every week Dr. Joseph Mercol

  14. Slide 14: Bringing growth and success stories for our customers

    …bringing growth and success stories for our customers… “Our Our MegaRed MegaRed® krill oil +58% Schiff product delivered particularly strong growth…” Fiscal Q3 10 5,7 ‐ Bruce Wood, President and Chief 36 3,6 Executive Officer of Schiff Net income Source: Schiff Nutrition International, Inc., [milli

  15. Slide 15: Helping close new agreements in the American market

    …and helping Aker BioMarine close new important agreements in the h American market k SSpecial i l stores Mass Internet Vitamin + Pharmacy retailers health stores existing existing new expanding 9 9 9 9 Th preferred The f d partner t 15 part of Aker © Aker |

  16. Slide 16: Starting to approach Asia, first agreement in Taiwan

    Aker BioMarine is starting to approach Asia, and has signed its first agreement in Taiwan Asian market Compson – new agreement 30 3% ƒ Leading d ingredient d d distributor b 25 ƒ 1400 customers in Taiwan CAGR 28 2008 Retail ssales ƒ Repr. key brands from overseas 20 2% R 2008‐13 [bn U$] 15 18 10 1%

  17. Slide 17: Disclaimer

    Disclaimer ƒ This Document includes and is based, inter alia, on forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. These statements and this Document are based on current expectations expectations, estimates and projecti

Aker BioMarine — Q1 2010 Earnings Presentation on 6ix